A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

October 25, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Advanced Breast Cancer
Interventions
DRUG

MEN2312

MEN2312 administered as oral tablets.

DRUG

Elacestrant

Elacestrant administered as oral tablets.

Trial Locations (38)

10016

NOT_YET_RECRUITING

NYU Langone Medical Center - Laura and Issac Perlmutter Cancer Center, New York

21287

NOT_YET_RECRUITING

Sidney Kimmel Comprehensive Cancer Center, Baltimore

22031

RECRUITING

NEXT Virginia, Fairfax

28203

NOT_YET_RECRUITING

Levine Cancer Institute - Atrium Health - Oncology, Charlotte

30458

NOT_YET_RECRUITING

Emory University - Winship Cancer Institute (WCI) - Oncology, Atlanta

32224

NOT_YET_RECRUITING

Mayo Clinic Comprehensive Cancer Center, Jacksonville

32701

RECRUITING

Advent Health (Florida Hospital), Altamonte Springs

32827

RECRUITING

Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando

33612

NOT_YET_RECRUITING

Moffitt Cancer Center, Tampa

34232

RECRUITING

Florida Cancer Specialists & Research Institute (FCS) - Sarasota, Sarasota

37203

RECRUITING

SCRI Oncology Partners Group, Nashville

49546

RECRUITING

START Midwest - Oncology, Grand Rapids

52242

NOT_YET_RECRUITING

University of Iowa Hospital and Clinics, Iowa City

53226

NOT_YET_RECRUITING

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

53792

NOT_YET_RECRUITING

University of Wisconsin - UW Carbone Cancer Center, Madison

55905

NOT_YET_RECRUITING

Mayo Clinic, Rochester

60612

NOT_YET_RECRUITING

University of Illinois at Chicago - Hematology/Oncology, Chicago

60637

NOT_YET_RECRUITING

University of Chicago, Chicago

66205

NOT_YET_RECRUITING

University of Kansas Medical Center, Richard & Annette Bloch Cancer Care Pavilion - Blood & Marrow Transplantation, Westwood

72703

RECRUITING

Highlands Oncology Group, Springdale

77030

RECRUITING

UT MD Anderson Cancer Center, Houston

78229

RECRUITING

South Texas Accelerated Research Therapeutics, San Antonio

RECRUITING

University of Texas Health Science Center San Antonio, San Antonio

84119

RECRUITING

START Mountain, West Valley City

85054

NOT_YET_RECRUITING

Mayo Clinic Cancer Center, Phoenix

90404

RECRUITING

UCLA Hematology Oncology - Parkside, Santa Monica

91010

NOT_YET_RECRUITING

City of Hope Medical Center, San Francisco

94115

NOT_YET_RECRUITING

Helen Diller Family Comprehensive Cancer Center, San Francisco

97213

NOT_YET_RECRUITING

Earle A. Chiles Research Institute Providence Cancer Center, Portland

98104

NOT_YET_RECRUITING

Swedish Cancer Institute - Oncology, Seattle

98109

NOT_YET_RECRUITING

University of Washington/Seattle Cancer Care Alliance - Clinical Research - Clinical Research Division, Seattle

92093-0698

RECRUITING

UC San Diego Moores Cancer Center, La Jolla

06511

RECRUITING

Yale Comprehensive Cancer Center, New Haven

02114

RECRUITING

Massachusetts General Hospital Cancer Center, Boston

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

08816

NOT_YET_RECRUITING

Astera Cancer Care, East Brunswick

10065-6800

NOT_YET_RECRUITING

Memorial Sloan-Kettering Cancer Center (MSKCC), New York

75390-7208

NOT_YET_RECRUITING

UT Southwest Medical Center, Dallas

All Listed Sponsors
lead

Stemline Therapeutics, Inc.

INDUSTRY